Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
Survey No. 250-252,, Turkapally Village, Shameerpet Mandal
Hyderabad; Andhra Pradesh; Map
Postal Code: 500078
Tel: 23480430/ 2348
Fax: 2348
Email: @zenotech.co.in
Website: http://www.zenotechlab.com

Full name: Zenotech Laboratories Ltd.

Previous name(s): SUNLINE TECHNOLOGIES LTD (2000)

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 1630134
IN-CIN: L27100AP1989PLC010122
ISIN: INE486F01012
Incorporation Date: 1989

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

Capsules, Interleukin - II, Granulocyte Macrophage Colony Stimulating Factor (G-MCSF), Granulocyte Colony Stimulating Factor (G-CSF), Granulated Fertilisers (Mixture), Lyophised Injections, Injections, Pharmaceutical Products, Tablets & Capsules

More

Company Description

Zenotech Laboratories Limited (Zenotech) is an India-based pharmaceutical company engaged in a business of manufacture and trading of pharmaceuticals products and also manufactures bio-technology products. Its pharmaceutical product portfolio serves niche therapy areas, including oncology and anesthesiology. The company was formerly known as Sunline Technologies Limited and changed its name to Zenotech Laboratories Limited in August 2004. The company was incorporated in 1989 and is based in Hyderabad,…

More

Basic Information

Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Quote Chart

Quote Summary

Last Price 54.40
Volume 6,885
Turnover 369,725
Index
Market Bombay Stock Exchange
Ticker 532039
Market Cap Market Cap 1,872,992
52 Week High 54.40
52 Week Low 33.75
Price to Earnings (P/E) -9.8
Earnings per Share (EPS) -5.55
Dividend Yield
Bookvalue 17,064
Enterprise Value 2,265,024
Quote updated on April 28, 2017
Note: data in INR Thousands.

Export-Import

2013: Imports INR 11,620.90 Thousands
Import connections ('000)
Total(187.75)
2013: Exports INR 4,532.00 Thousands
Export connections ('000)
Total(73.22)

Key Executives

Chairman
More

Ownership Details

Indian Promoters
46.85%
More

Key Stats

Select Items to chart them. 2017 Q3C
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets N/A
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: Dion Global Solutions Limited, EMIS Company Database.

Financials

Competitors - India

INR | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2016
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest